BIOTECHNOLOGY SERVICE AGREEMENT

          THIS BIOTECHNOLOGY SERVICE AGREEMENT (the "Agreement"),
is made as of this 1st day of July, 1994, by and between LG
SEEDS, INC., 4001 North War Memorial Drive, Peoria, IL  61614, a
Delaware corporation (the "Company"), and BIOCEM S.A., 24, avenue
des Landais, 63170 Aubiere, France, a company organized under the
laws of France, and registered in Riom, France under the
Commercial Registration Number B378 710 115 ("BIOCEM").

          WHEREAS, BIOCEM participates in long-term research
projects in the field of biotechnology on a worldwide basis (the
"Biotechnology Research Projects"); and

          WHEREAS, access to the results of such Biotechnology
Projects, and any related studies or recommendations performed or
made by BIOCEM with respect thereto (collectively, the
"Results"), would be of great value to the Company;

          NOW, THEREFORE, in consideration of the above and the
mutual covenants and agreements set forth herein, the parties
hereto agree as follows:

          1.  Provision of Services.  BIOCEM agrees to provide
the following specific services to the Company (collectively, the
"Specific Services"):

                  (a)  With respect to BIOCEM's Biotechnology Research
          Projects, BIOCEM shall give access to the Company to the
          Results of its ongoing research activities on a yearly basis.

                  (b)  With respect to scientific advice in the field
          of biotechnology, BIOCEM shall allow the Company's 
          management to have access to BIOCEM's staff for advice and
          consultation within their area of expertise.

                  (c)  With respect to new Biotechnology Research
          Projects, the Company shall have the right to suggest and
          make recommendations to BIOCEM regarding strategic choices.

                  (d)  With respect to marketability of Biotechnology
          Products and Techniques, BIOCEM shall provide its technical
          expertise to the Company to assess the future marketability
          of Biotechnology Products and Techniques. 

          2.  Funding, Term and Termination.  For the one-year period
beginning on the date of this Agreement, the Company
agrees to provide funding for the Research Projects in an amount
equal to the annual dollar amount set forth on Exhibit A attached
hereto (the "Annual Funding Amount").  Either party may terminate
this Agreement at the end of such one-year period, and at the end
of any subsequent one-year period, upon thirty (30) days advance
written notice.  If the Agreement is not so terminated, then the
Agreement shall automatically renew for a one-year period.  Upon
such automatic renewal, the parties agree to negotiate in good
faith (i) the scope of the Results to be provided by BIOCEM and
(ii) the Annual Funding Amount to be paid by the Company
(collectively, the "Renegotiated Terms") and to update Exhibit A
accordingly.  If the parties cannot mutually agree on such
Renegotiated Terms within thirty (30) days, then the Agreement
shall be automatically renewed upon the same terms as the
preceding year.  The Company shall pay the Annual Funding Amount
to BIOCEM in four (4) quarterly installments on the last business
day of each fiscal quarter.

          3.  Entire Agreement.  This Agreement, together with
Exhibit A (as it may be amended from time to time), which shall
be incorporated herein by reference, embodies the entire
agreement and understanding between the parties hereto with
respect to the subject matter hereof and supersedes all prior
agreements and understandings relating thereto.

          4.  Assignment.  This Agreement shall be binding upon
and shall inure to the benefit of the parties hereto and their
respective successors and permitted assigns.  No party hereto may
assign any of its rights hereunder without the prior written
consent of the other party hereto.

          5.  Miscellaneous.  This Agreement shall be governed by
and construed in accordance with the laws of the State of
Illinois.  Except as otherwise expressly provided herein, no
provision hereof may be waived, amended or otherwise modified
except by a written agreement signed by each party hereto.  The
headings of this Agreement are for purposes of reference only and
shall not limit or otherwise affect the meaning hereof.  This
Agreement may be executed in one or more counterparts, each of
which shall be deemed an original, but all of which taken
together shall constitute one and the same instrument.

          IN WITNESS WHEREOF, the parties hereto have executed
this Agreement as of the date first above written.

LG SEEDS, INC.


By:  /s/ J.C. Gouache
     Name:     J.C. Gouache             
     Title:    President & Chief Operating Officer


BIOCEM S.A.


By:/s/ D. Vial
     Name:  D. Vial
  Title:  Chief Executive Officer


                                EXHIBIT A

                     BIOTECHNOLOGY SERVICE AGREEMENT



EXHIBIT A to BIOTECHNOLOGY SERVICE AGREEMENT dated July 1, 1994,
is executed this 1st day of July 1994, by and between BIOCEM S.A.
and LG SEEDS, INC.

For the one-year period beginning on July 1, 1994, LG Seeds, Inc.
agrees to pay a fee (the "Annual Fee") of $30,000.00 for services
rendered under the Agreement.



LG SEEDS, INC.                     BIOCEM S.A.

/s/ J.C. Gouache                          /s/ D. Vial

J.C. GOUACHE                    By        D. Vial
President and Chief Operating  Title      Chief Executive Officer
Officer